Secondary osteoporosis
- PMID: 27346916
- PMCID: PMC4919174
- DOI: 10.18773/austprescr.2016.038
Secondary osteoporosis
Abstract
Secondary osteoporosis is less common than primary osteoporosis. It may be suspected in patients who present with a fragility fracture despite having no risk factors for osteoporosis. In addition, secondary osteoporosis should be considered if the bone density Z-score is -2.5 or less. Consider the fracture site and presence of other clinical clues to guide investigations for an underlying cause. The tests to use are those that are indicated for the suspected cause. Baseline investigations include tests for bone and mineral metabolism (calcium, phosphate, alkaline phosphatase, 25-hydroxyvitamin D, parathyroid hormone), liver and kidney function, full blood count and thyroid-stimulating hormone. More detailed testing may be required in patients with severe osteoporosis.
Keywords: Z-score; biopsy of bone; bone density; fracture of bone; osteoporosis.
Conflict of interest statement
Conflict of interest: none declared
Similar articles
-
Osteoporosis and bone mineral metabolism disorders in cirrhotic patients referred for orthotopic liver transplantation.Calcif Tissue Int. 1997 Feb;60(2):148-54. doi: 10.1007/s002239900205. Calcif Tissue Int. 1997. PMID: 9056162
-
The management of secondary osteoporosis.Best Pract Res Clin Rheumatol. 2005 Dec;19(6):1021-37. doi: 10.1016/j.berh.2005.06.005. Best Pract Res Clin Rheumatol. 2005. PMID: 16301195 Review.
-
Effect of recombinant human parathyroid hormone (1-84) on vertebral fracture and bone mineral density in postmenopausal women with osteoporosis: a randomized trial.Ann Intern Med. 2007 Mar 6;146(5):326-39. doi: 10.7326/0003-4819-146-5-200703060-00005. Ann Intern Med. 2007. PMID: 17339618 Clinical Trial.
-
Contributors to secondary osteoporosis and metabolic bone diseases in patients presenting with a clinical fracture.J Clin Endocrinol Metab. 2011 May;96(5):1360-7. doi: 10.1210/jc.2010-2135. Epub 2011 Mar 16. J Clin Endocrinol Metab. 2011. PMID: 21411547
-
Strategies for treatment to prevent fragility fractures in postmenopausal women.Best Pract Res Clin Rheumatol. 2009 Dec;23(6):727-40. doi: 10.1016/j.berh.2009.09.001. Best Pract Res Clin Rheumatol. 2009. PMID: 19945685 Review.
Cited by
-
Sirt1: An Increasingly Interesting Molecule with a Potential Role in Bone Metabolism and Osteoporosis.Biomolecules. 2024 Aug 8;14(8):970. doi: 10.3390/biom14080970. Biomolecules. 2024. PMID: 39199358 Free PMC article. Review.
-
Preoperative Thyroid-Stimulating Hormone Levels and Three-Year Mortality in Elderly Hip Fracture Patients: Insights from a Prospective Cohort Study.Med Sci Monit. 2024 Aug 5;30:e944465. doi: 10.12659/MSM.944465. Med Sci Monit. 2024. PMID: 39099160 Free PMC article.
-
Osteoporosis: Investigations and Monitoring.Indian J Orthop. 2023 Dec 1;57(Suppl 1):70-81. doi: 10.1007/s43465-023-01019-w. eCollection 2023 Dec. Indian J Orthop. 2023. PMID: 38107808 Review.
-
Methotrexate Increases Serum Calcium Levels in Patients with Rheumatoid Arthritis: A Retrospective Study at a Referral Hospital in Indonesia.Curr Ther Res Clin Exp. 2023 Nov 12;99:100726. doi: 10.1016/j.curtheres.2023.100726. eCollection 2023. Curr Ther Res Clin Exp. 2023. PMID: 38090720 Free PMC article.
-
Continuous positive airway pressure treatment improves bone mineral density in men affected by severe obstructive sleep apnea syndrome.J Clin Sleep Med. 2024 Jan 1;20(1):67-73. doi: 10.5664/jcsm.10796. J Clin Sleep Med. 2024. PMID: 37677073
References
-
- Ferrari S, Bianchi ML, Eisman JA, Foldes AJ, Adami S, Wahl DA, et al. IOF Committee of Scientific Advisors Working Group on Osteoporosis Pathophysiology . Osteoporosis in young adults: pathophysiology, diagnosis, and management. Osteoporos Int 2012;23:2735-48. 10.1007/s00198-012-2030-x - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources